Matching slides 24,547
Current window 16,471-16,500
Pages 819
Rows per page 30
Slide function: Present Solutionclear collectionreset all

Slide function

16,471-16,500 of 24,547

filter-aware
10
The slide uses a structural biology visualization and two dose-response curves to establish bio-equivalence and differentiation.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a comparative table for safety metrics and a bar chart for ADA rates to establish clinical equivalence/safety.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
21
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
22
The funnel diagram illustrates the selection criteria: Monomer/Trimer binder -> Picomolar potency -> Extended half-life.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
27
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
28
The slide uses a biological process diagram to illustrate the mechanism of action for three distinct therapeutic assets.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
10
The slide uses a problem-solution framework to justify the engineering approach for each therapeutic program.Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations 1 hit
24
The slide uses a hub-and-spoke diagram for the mechanistic combinations.Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations 1 hit
25
The slide outlines the clinical strategy for optimizing nemvaleukin dosing, referencing specific clinical trials (ARTISTRY-3 and ARTISTRY-6).Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations 1 hit
32
The slide uses a process flow diagram to explain the therapeutic mechanism.Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations 1 hit
33
Includes a bar chart showing dose-dependent PD response in a mouse model and a schematic of the split IL-12 mechanism.Alkermes | Investor Presentation Deck | 37 slides · Mural Oncology
Conference presentation Investor relations 1 hit
03
The slide outlines the core therapeutic strategy of Arbutus Biopharma.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide highlights the mechanism of action and key therapeutic benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
23
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
07
Astra | Investor Presentation Deck | 22 slidesAstra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations Beat · Solution1 hit
10
The slide features a high-quality photo of the engine hardware alongside key performance claims.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
11
The slide uses icons to represent each capability, paired with a photograph of the thruster in operation.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
12
The slide uses a 3D render with callouts to label specific hardware components.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
13
The slide features a high-quality photograph of the physical hardware components of the propulsion system.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
19
The slide emphasizes the portability and operational efficiency of the launch system.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
07
Includes a map of global disease burden and specific clinical trial milestones.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
14
Includes a map of global disease burden and key product features.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
Includes a map of global disease burden and key epidemiological metrics for OUD.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
23
Includes a map of global disease burden and key product specs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
04
The slide uses a value chain framework to show disintermediation of traditional ad-tech layers.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a value-chain style layout to illustrate the flow from demand (advertisers/agencies) through the Azerion platform to supply (publishers).Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Solution1 hit
09
The slide uses a five-column layout to categorize the company's service offerings.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
10
The slide uses a visual matrix to contrast Azerion's full-stack integration against fragmented competitors.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
12
The slide uses a funnel-like visual structure to categorize the value proposition.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit